Akèy › Leksemi mieloïd egi › New York › Queens
Etid klinik pou Leksemi mieloïd egi nan Queens, NY
21 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Queens Hospital Center, Jamaica · 2 mi lwen
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Ap rekriteFaz 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
A Study of CRD3874-SI in People With Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi lwen
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Ap rekriteFaz 2
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Ap rekriteFaz 3
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
- NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Ap rekriteFaz 2
- Clinical Research Allicance, Westbury · 14 mi lwen
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Ap rekriteFaz 1/2
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park · 9 mi lwen
- NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Ap rekriteFaz 3
- Cohen Children's Medical Center, Queens
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Ap rekriteFaz 1
- Northwell Health, LLC PRIME, Lake Success · 9 mi lwen
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi lwen
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi lwen
A Study of Revumenib and Mezigdomide in People With Leukemia
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi lwen
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre · 10 mi lwen
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Ap rekriteFaz 2/3
- New York University Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre · 10 mi lwen
Etid Leksemi mieloïd egi nan lòt vil
- Houston, TX85 etid
- New York City, NY51 etid
- Boston, MA44 etid
- Baldwin Park, CA40 etid
- Seattle, WA40 etid
- Columbus, OH35 etid
- Philadelphia, PA34 etid
- Durham, NC33 etid
- Atlanta, GA30 etid
- Tampa, FL29 etid
- Chicago, IL26 etid
- Portland, OR25 etid
Lòt etid nan Queens
- Kansè nan tete63 etid
- Kansè Poumon ki pa ti selil49 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Kansè ovè28 etid
- Kansè pwostat27 etid
- Kansè (tout kalite)26 etid
- Kansè Endomèt25 etid
- Kansè poumon22 etid
- Karsinòm selil skuamèz tèt ak kou20 etid
- Myelom Miltip20 etid
- Kansè pankreyas20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.